Digital collaboration here to stay beyond pandemic for Merck, Pfizer, others

A recent survey pulled medical affairs thought leaders and found that a majority see asynchronous virtual options in conjunction with in-person as the preferred path moving forward to conduct advisory board meetings, steering meetings, and other such communications, versus just in-person.